Nervous system

NervGen Pharma: Proof that NVG-291 works?

Tantalizing anecdotal “evidence” has just been published suggesting that NervGen’s prospective wonder-drug, NVG-291, is delivering the goods.
Screenshot of Dr. Monica Perez being interviewed by NBC5 Chicago

NervGen: Are amazing human trial results leaking out?

NervGen Pharma Corp. (TSXV:NGEN) hopes to commercialize the world’s first ever FDA-approved drug to treat spinal cord injuries.